| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 57.428 | 36.685 | 1.483 | 0 | 0 | 3.758 | 7.698 | 0 | 0 | 0 |
| Total Income - EUR | 59.645 | 38.653 | 61.324 | 580 | 0 | 3.758 | 7.698 | 0 | 14 | 0 |
| Total Expenses - EUR | 61.899 | 6.659 | 31.939 | 1.231 | 263 | 17.246 | 23.549 | 5.361 | 2.210 | 943 |
| Gross Profit/Loss - EUR | -2.254 | 31.995 | 29.385 | -651 | -263 | -13.488 | -15.851 | -5.361 | -2.197 | -943 |
| Net Profit/Loss - EUR | -2.254 | 30.850 | 28.772 | -668 | -263 | -13.601 | -16.078 | -5.361 | -2.197 | -943 |
| Employees | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farmavita Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 25.907 | 24.963 | 776 | 624 | 476 | 333 | 65 | 0 | 0 | 0 |
| Current Assets | 38.159 | 14.009 | 70.461 | 68.674 | 67.200 | 53.703 | 34.815 | 10.024 | 9.312 | 8.618 |
| Inventories | 0 | 0 | 4.218 | 4.141 | 4.061 | 12.205 | 217 | 0 | 0 | 0 |
| Receivables | 30.460 | 8.532 | 8.887 | 8.869 | 8.704 | 8.604 | 8.452 | 8.728 | 8.872 | 8.397 |
| Cash | 7.699 | 5.477 | 4.818 | 55.664 | 54.435 | 32.893 | 26.146 | 1.296 | 440 | 221 |
| Shareholders Funds | 7.656 | 38.428 | 66.549 | 64.660 | 63.145 | 48.347 | 31.198 | 4.588 | 2.377 | 1.421 |
| Social Capital | 47 | 47 | 46 | 45 | 44 | 43 | 42 | 43 | 42 | 42 |
| Debts | 56.410 | 544 | 4.688 | 4.638 | 4.531 | 5.689 | 3.682 | 5.436 | 6.934 | 7.197 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4791
|
|||||||||
Comments - Farmavita Srl